Change Language

Select Language

Global Ablation Devices Market to Reach US$ 9.1 Billion by 2027, Propelled by the Rising Prevalence of Chronic Diseases

Published on Sep 29, 2022

The latest report by IMARC, titled “Ablation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, finds that the global ablation devices market size reached US$ 4.7 Billion in 2021. Ablation devices refer to medical instruments used to remove abnormal body tissues for therapeutic purposes. Some of the most common ablation devices include fluid-cooled, tissue contact, temperature-controlled, robotic catheter manipulation and laser ablators, tissue contact, and spray probes. They use laser, ultrasound, radiofrequency (RF), cryoablation, microwave, and hydrothermal technologies. These devices are also used for curing numerous diseases in various medical domains, such as cancer, ophthalmology, gynecology, and cardiovascular. In recent years, ablation devices have gained traction due to their employment as an alternative to surgical treatment for various chronic illnesses.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of the associated industries. These observations will be integrated into the report.

Global Ablation Devices Market Trends:

One of the primary factors driving the market is the rising prevalence of chronic diseases, including atrial fibrillation and chronic venous insufficiency (CVI), and cancer. Additionally, ablation treatments cause minimal damage and blood loss, which has led to an increase in the product adoption rate globally. Other than this, the growing awareness among the masses about the availability of effective ablation processes is creating a positive market outlook. Besides this, the extensive employment of electrophysiology to eliminate abnormal tissues causing cardiac arrhythmia or irregular heart rhythms is boosting the product demand. In line with this, numerous technological improvements, such as the introduction of next-generation ablation devices with robotic navigation systems, are propelling the market growth. Furthermore, the treatment of superficial vein reflux is improving with the development of non-tumescent, non-thermal, and non-sclerosant endovenous ablation devices. Other growth-inducing factors include the inflating disposable incomes of the masses and exponential growth in the medical industry. Looking forward, IMARC Group expects the market value to reach US$ 9.1 Billion by 2027, expanding at a CAGR of 11.7% during the forecast period (2022-2027).

Market Summary:

  • Based on device technology, the market has been divided into radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others.
  • On the basis of the application, the market has been segmented into cancer treatment, cardiovascular disease treatment, ophthalmologic treatment, gynecological treatment, urological treatment, cosmetic surgery, and others.
  • Based on the end user, the market has been segregated into hospitals, ambulatory surgical centers, and others.
  • Region-wise, the market has been classified into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Abbott Laboratories, AngioDynamics Inc., AtriCure Inc., Boston Scientific Corporation, CONMED Corporation, Elekta AB (publ), Johnson & Johnson, Medtronic plc, Olympus Corporation and Smith & Nephew plc.
     

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

4